BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36277893)

  • 1. Identification of RPS7 as the Biomarker of Ferroptosis in Acute Kidney Injury.
    Zhang H; Liu X; Zhou L; Deng Z; Wang Y
    Biomed Res Int; 2022; 2022():3667339. PubMed ID: 36277893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of ferroptosis-related gene SLC2A1 as a novel prognostic biomarker in AKI.
    Wang H; Li Y; Liu X; Wu Y
    Aging (Albany NY); 2024 Mar; 16(6):5634-5650. PubMed ID: 38517368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of the diagnostic signature associated with immune microenvironment of acute kidney injury based on ferroptosis-related genes through integrated bioinformatics analysis and machine learning.
    Chen Y; Liu A; Liu H; Cai G; Lu N; Chen J
    Front Cell Dev Biol; 2023; 11():1210714. PubMed ID: 37576602
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioinformatics analysis and experimental validation reveal the anti-ferroptosis effect of FZD7 in acute kidney injury.
    Long H; Zhang H; Ran L; Xiang L; Xie P; Zou L; Yi L; Tang X; Chen L; Li Q; Zhao H
    Biochem Biophys Res Commun; 2024 Jan; 692():149359. PubMed ID: 38071893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis.
    Hu Z; Zhang H; Yi B; Yang S; Liu J; Hu J; Wang J; Cao K; Zhang W
    Cell Death Dis; 2020 Jan; 11(1):73. PubMed ID: 31996668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes.
    Kim DH; Choi HI; Park JS; Kim CS; Bae EH; Ma SK; Kim SW
    Redox Biol; 2022 Aug; 54():102382. PubMed ID: 35767918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury.
    Gong Q; Lai T; Liang L; Jiang Y; Liu F
    Mol Med; 2023 Oct; 29(1):140. PubMed ID: 37875838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WBP2 restrains the lysosomal degradation of GPX4 to inhibit ferroptosis in cisplatin-induced acute kidney injury.
    Deng Z; Wang Y; Liu J; Zhang H; Zhou L; Zhao H; Han Y; Yan S; Dong Z; Wang Y; Dai Y; Deng F
    Redox Biol; 2023 Sep; 65():102826. PubMed ID: 37516014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Cx43 reduces cisplatin-induced acute renal injury by inhibiting ferroptosis.
    Yu M; Lin Z; Tian X; Chen S; Liang X; Qin M; Zhu Q; Wu Y; Zhong S
    Food Chem Toxicol; 2021 Dec; 158():112672. PubMed ID: 34785303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myo-inositol oxygenase expression profile modulates pathogenic ferroptosis in the renal proximal tubule.
    Deng F; Sharma I; Dai Y; Yang M; Kanwar YS
    J Clin Invest; 2019 Nov; 129(11):5033-5049. PubMed ID: 31437128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Targeted Antioxidant SKQ1 Ameliorates Acute Kidney Injury by Inhibiting Ferroptosis.
    Song J; Sheng J; Lei J; Gan W; Yang Y
    Oxid Med Cell Longev; 2022; 2022():2223957. PubMed ID: 36193064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury.
    Wang Y; Zhang M; Bi R; Su Y; Quan F; Lin Y; Yue C; Cui X; Zhao Q; Liu S; Yang Y; Zhang D; Cao Q; Gao X
    Redox Biol; 2022 May; 51():102262. PubMed ID: 35180475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Correlation between Ferroptosis and m6A Methylation in Patients with Acute Kidney Injury.
    Ni L; Bai R; Zhou Q; Yuan C; Zhou LT; Wu X
    Kidney Blood Press Res; 2022; 47(8):523-533. PubMed ID: 35569444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal lncRNA TUG1 derived from human urine-derived stem cells attenuates renal ischemia/reperfusion injury by interacting with SRSF1 to regulate ASCL4-mediated ferroptosis.
    Sun Z; Wu J; Bi Q; Wang W
    Stem Cell Res Ther; 2022 Jul; 13(1):297. PubMed ID: 35841017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic analysis identifies potential biomarkers and therapeutic targets of septic-shock-associated acute kidney injury.
    Tang Y; Yang X; Shu H; Yu Y; Pan S; Xu J; Shang Y
    Hereditas; 2021 Apr; 158(1):13. PubMed ID: 33863396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfide:quinone oxidoreductase alleviates ferroptosis in acute kidney injury via ameliorating mitochondrial dysfunction of renal tubular epithelial cells.
    Cai F; Li D; Xie Y; Wang X; Ma H; Xu H; Cheng J; Zhuang H; Hua ZC
    Redox Biol; 2024 Feb; 69():102973. PubMed ID: 38052107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRMT4 interacts with NCOA4 to inhibit ferritinophagy in cisplatin-induced acute kidney injury.
    Zhou L; Deng Z; Wang Y; Zhang H; Yan S; Kanwar YS; Wang Y; Dai Y; Deng F
    FASEB J; 2024 Apr; 38(7):e23584. PubMed ID: 38568836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of AKI signatures and classification patterns in ccRCC based on machine learning.
    Wang L; Peng F; Li ZH; Deng YF; Ruan MN; Mao ZG; Li L
    Front Med (Lausanne); 2023; 10():1195678. PubMed ID: 37293297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk among proximal tubular cells, macrophages, and fibroblasts in acute kidney injury: single-cell profiling from the perspective of ferroptosis.
    Wang Y; Shen Z; Mo S; Zhang H; Chen J; Zhu C; Lv S; Zhang D; Huang X; Gu Y; Yu X; Ding X; Zhang X
    Hum Cell; 2024 Jul; 37(4):1039-1055. PubMed ID: 38753279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VPA improves ferroptosis in tubular epithelial cells after cisplatin-induced acute kidney injury.
    Li Y; Li K; Zhao W; Wang H; Xue X; Chen X; Li W; Xu P; Wang K; Liu P; Tian X; Fu R
    Front Pharmacol; 2023; 14():1147772. PubMed ID: 37153759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.